| Market Capitalization (Millions $) |
69 |
| Shares
Outstanding (Millions) |
6 |
| Employees |
62 |
| Revenues (TTM) (Millions $) |
28 |
| Net Income (TTM) (Millions $) |
-41 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Assembly Biosciences Inc
Assembly Biosciences Inc is a biotechnology company that focuses on developing innovative therapeutics for various diseases. The company primarily works in the field of microbiome, which refers to the collection of microorganisms residing in the human body.
Assembly Biosciences aims to develop therapies that can address serious health conditions by selectively targeting the microbiome. They believe that by modifying the microbiome, it is possible to bring about positive changes in human health.
The company's therapeutic pipeline includes potential treatments for hepatitis B virus (HBV), C. difficile infection, and other gastrointestinal conditions. Assembly Biosciences is known for its expertise in molecular biology, biochemistry, and microbiology, which enables them to develop novel drug candidates.
In addition to developing their own products, Assembly Biosciences also collaborates with other pharmaceutical companies to advance research and development in the microbiome space. They work on identifying new drug targets, conducting clinical trials, and ultimately bringing innovative therapies to patients in need.
Overall, Assembly Biosciences Inc is a biotech company that focuses on harnessing the power of the microbiome to develop effective treatments for various diseases, particularly in the field of gastroenterology.
Company Address: Two Tower Place South San Francisco 94080 CA
Company Phone Number: 509-4583 Stock Exchange / Ticker: NASDAQ ASMB
|
0.95%